Montpellier, France, August 29, 2016 – MEDTECH (Euronext, FR0010892950 – ROSA), a company specialized in designing, developing and marketing innovative surgical assistance robots, will be showcasing its ROSA® robot at three major congresses in September.
The European Association of Neurosurgical Societies (EANS) congress
This event, which takes place in Athens, Greece, from September 4 to 8, gathers around 2,500 experts in surgery of the central nervous system (brain and spine).
At the congress, Dr. Thomas Freiman, a neurosurgeon at Frankfurt University Hospital, will be presenting the results of his study on robotic accuracy in stereotactic procedures with the assistance of ROSA® Brain (September 7, 11:00 a.m. and 4.30 p.m. local time at Medtech's Booth #15).
Click here for further information about the congress: http://eans2016.com/
The Congress of Neurological Surgeons (CNS) annual meeting
This congress, scheduled in San Diego, CA, USA, from September 26 to 28, is a major event in the field of neurosurgery, gathering around 3,000 specialists in cranial and spine surgery. Two ROSA® robots will be showcased at Medtech's Booth #939 for demonstrations of minimally invasive surgical procedures of the central nervous system.
Click here for further information about the congress: https://www.cns.org/annual-meeting-2016
The annual congress of the European Society for Stereotactic and Functional Neurosurgery (ESSFN)
This scientific meeting, organized from September 28 to October 1 in Madrid, Spain, will gather leading European centers for neurosurgery. Experts in the field will be able to learn about the benefits of using the ROSA® robot for minimally invasive brain and spine surgery at Medtech's Booth #15.
On Thursday, September 29, three neurosurgeons of international renown will present their scientific conclusions on robotic activity for minimally invasive brain and spine surgery with the assistance of the ROSA® robotic surgery system:
- Pr. Stephan Chabardes from Grenoble university Hospital in France will be sharing his experience with the ROSA® robot for deep brain stimulation;
- Pr. Mohammad Maarouf, a neurosurgeon at Krankenhaus Merheim in Cologne, Germany, will also discuss his robotic experience with ROSA® for deep brain stimulation.
- Dr. Michel Lefranc, a neurosurgeon at Amiens University Hospital in France, will complete the scientific session with the results of his clinical activity in robotic surgery for the brain and spine.
Click here for further information about the congress: http://www.essfncongress.org/en/
|About MEDTECH |
Founded in 2002 by Bertin NAHUM and based in Montpellier, MEDTECH is a European specialist in the design, development and marketing of innovative robotic appliances to assist surgeons during their medico-surgical interventions, thus contributing to the implementation of safer, more efficient, less-invasive treatment.
In 2007, MEDTECH developed ROSA®, an innovative technological device devoted to brain surgery procedures. ROSA® has been approved in Europe, the United States and Canada.
In 2013 MEDTECH received the “European Company of the Year Award” in the “robotic neurosurgery” category from Frost & Sullivan.
In July 2014, MEDTECH obtained the CE marking for its new product ROSA® Spine, a robotic- assistive device for minimally invasive surgery of the spine.
In October 2014, MEDTECH won the “Révélation” prize in the Mediterranean Deloitte Technology Fast 50 Awards.
In 2015 MEDTECH received the “2016 Company of the Year Award” in the “robotic neurosurgery” category from Frost & Sullivan.
In November 2015, MEDTECH was honored by Deloitte In Extenso for its excellent performance in the Technology Fast 50 Mediterranean Awards, in the “listed company” category.
In January 2016, MEDTECH obtained the FDA clearance for its new product, ROSA® Spine, a robotic-assistive device for minimally invasive surgery of the spine.